2018, Number 6
Announcing the 1st SINGLE TOPIC CONFERENCE 2019-GENOMIC MEDICINE IN HEPATOLOGY: OBESITY AND LIVER DAMAGE to be Held in Guadalajara, Jalisco, Mexico, February 21-23, 2019
Panduro A
Language: English
References: 0
Page: 1081-1082
PDF size: 77.82 Kb.
Text Extraction
Hepatology is a growing field in medicine that has achieved important advances in the diagnosis and treatment of liver diseases. Currently, obesity is an emerging public health problem affecting millions of people worldwide. By 2050, obesity has been projected to rise even more if prevention strategies are not implemented to curb this tendency. In Mexico as in other Latin American countries, multiple factors contribute towards the predisposition for obesity, starting with macro-level factors of globalization that shift societies towards a westernized lifestyle as well as other regional risk factors. Furthermore, obesity promotes metabolic abnormalities that can cause different grades of liver damage, i.e., fibrosis, cirrhosis, or liver cancer, due to non-alcoholic steatohepatitis (NASH), a comorbidity that is currently considered as the third cause of chronic liver disease after alcohol abuse and hepatitis viruses.